Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heterogeneous nuclear ribonucleoprotein A1 pseudogene 58 (HNRNPA1P58) is a processed pseudogene related to the HNRNPA1 gene, which encodes a protein involved in pre-mRNA processing, RNA splicing, and other aspects of RNA metabolism. Unlike the HNRNPA1 gene, HNRNPA1P58 contains mutations and does not produce a functional protein. While some pseudogenes are transcribed and may exert noncoding regulatory effects, there is currently no experimental evidence that HNRNPA1P58 has a functional role in human biology or disease. It is catalogued in several human gene databases, but should not be confused with its protein-coding parent, HNRNPA1, which is a functionally important RNA-binding protein relevant to various cellular processes and diseases, including some cancers and neurodegenerative disorders. HNRNPA1P58 is sometimes confused with HNRNPA1, which is a functionally significant protein and therapeutic interest target. The pseudogene HNRNPA1P58 is not therapeutically actionable or recognized as a drug target.
None. No mechanism of action is known, as it is not an active target
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heterogeneous nuclear ribonucleoprotein A1 pseudogene 58 (HNRNPA1P58).